U.S. Food & Drug Administration (FDA) FDA/CFSAN Cosmetics News Update: Warning Letters Address Drug Claims Made for Products Marketed as Cosmetics

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: U.S. Food & Drug Administration (FDA) FDA/CFSAN Cosmetics News Update: Warning Letters Address Drug Claims Made for Products Marketed as Cosmetics

You are subscribed to FDA’s Cosmetics News. Here is our latest update:

• Warning Letters Address Drug Claims Made for Products Marketed as Cosmetics:
  Warning Letter to Reviva Labs, Inc. Cites Unapproved Drug Claims

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

 

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)